Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population

03 November 2020 : Clinical Research

Liwen Hong^1AE, Yuan Wang^2BD, Tianyu Zhang^1CF, Chen Zhang^1BC, Lei Wang^1AD, Liying Wang^3EG*, Zhengting Wang^1AG, Jie Zhong^1AG

DOI: 10.12659/MSM.926635

Med Sci Monit 2020; 26:e926635

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Demographic and pathological characteristics of patients with P-NETs.

Demographic and pathological features		Number n=73
Gender	Male	29 (39.7%)
Age (years) at diagnosis	Median (range)	49 (16–75)
P-NENs subtype	Insulinoma	43 (58.9%)
	Non-insulinoma P-NENs	30 (41.1%)
	NF^*	29
	Gastrinoma	1
Surgery or not	Curative surgery	61 (83.6%)
Surgery or not	Non-resection	12 (16.4%)
Liver metastasis or not	No	61 (83.6%)
Liver metastasis or not	Yes	12 (16.4%)
Grade	G1	45 (61.6%)
	G2	20 (27.4%)
	G3	8 (11.0%)
Stage	I	45 (61.6%)
	II	16 (21.9%)
	III	0
	IV	12 (16.4%)
^* NF – non-functional tumor.

Back to the Article